Biontech AG Outbreak - First COVID-19 human vaccine trial test

Hey fellow Trader,
The uprising Biotechnology company from BNTX Mainz, Germany is on its final steps from developing a vaccine for the actual Bio-weapon health crisis from the "new flu" .
With Rolf Zinkernagel a brilliant Scientiests that can proudly say to win a nobelprice and a strong financial background , from big names in the Pharmaceutical field.

When BioNTech AG announced to start with the first human vaccine tests after getting an approval in Europa , a US approval should follow shortly after also.
We should expect News from those test in end May/june and if they´ve managed to create a proven vaccine afterwards im staying LONG in this Outbreak because its Trending and the Chances are high for a good R/R.

A Golden Cross is forming and the Overall Stock is positive and with a low beta so less correlation risk in this given "Crazy Market" .
So with a break of the 56 level we should see a strong move up.

Goals are high and i think it could touch the 100 mark again with reactive move down to given support levels if they arent successful with their vaccine Therapy.
STOPLOSS tight at 49,45

I hope this was helpful but it only displays my opionion and no financial adivce is given here.

Sincerly,
Sebastian
biontechbiotechnologyChart PatternsCoronavirus (COVID-19)coronavirusstockscovid-2019Technical IndicatorstechnologystockstestingTrend Analysistrialvaccine

Disclaimer